{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:23:23Z","timestamp":1779297803331,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.clinthera.2008.05.013","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:54:58Z","timestamp":1213433698000},"page":"845-857","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and safety profiles of a new S(\u2014)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Sung Ai","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namsik","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Hee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Jea","family":"Tahk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.05.013_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(00)02047-X","article-title":"Chiral switches","volume":"355","author":"Tucker","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.013_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00003088-200443050-00002","article-title":"Single-enantiomer drugs: Elegant science, disappointing effects","volume":"43","author":"Mansfield","year":"2004","journal-title":"Clinical Pharmacokinet"},{"key":"10.1016\/j.clinthera.2008.05.013_bib3","first-page":"187","article-title":"Chiral molecules in hypertension: Focus on S-amlodipine","volume":"52","author":"Adik-Pathak","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.clinthera.2008.05.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-022X(02)00124-0","article-title":"The importance of stereoselective determination of drugs in the clinical laboratory","volume":"54","author":"Rentsch","year":"2002","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.clinthera.2008.05.013_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrd915","article-title":"Putting chirality to work: The strategy of chiral switches","volume":"1","author":"Agranat","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clinthera.2008.05.013_bib6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1358\/dof.1999.024.11.559951","article-title":"Esomeprazole magnesium. H+\/K+-ATPase inhibitor antiulcer treatment of GERD","volume":"24","author":"Graul","year":"1999","journal-title":"Drugs Future"},{"key":"10.1016\/j.clinthera.2008.05.013_bib7","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1517\/13543784.7.12.2027","article-title":"Levalbuterol hydrochloride","volume":"7","author":"Handley","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clinthera.2008.05.013_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1358\/dof.1997.022.12.711853","article-title":"Pharmacodynamics, pharmacokinetics and toxicity of ibuprofen enantiomers","volume":"22","author":"Mayer","year":"1997","journal-title":"Drugs Future"},{"key":"10.1016\/j.clinthera.2008.05.013_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005344-200202000-00007","article-title":"Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine","volume":"39","author":"Zhang","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2008.05.013_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clinthera.2005.06.011","article-title":"Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: A multicenter, randomized, double-blind, parallel-group, 8-week comparison","volume":"27","author":"Lee","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.clinthera.2005.04.001","article-title":"Results of a multicenter, 8-week, parallel-group, randomized, double-blind, doubledummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension","volume":"27","author":"Park","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clinthera.2006.04.008","article-title":"Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebocontrolled, parallel-group, 8-week follow-up, noninferiority trial [published correction appears in Clin Ther. 2006;28:1245]","volume":"28","author":"Hong","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5414\/CPP44641","article-title":"Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects","volume":"44","author":"Park","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.clinthera.2007.09.018","article-title":"Results of a phase III, 8-week, multicenter, prospective, randomized, doubleblind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension","volume":"29","author":"Kim","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2006.11.008","article-title":"Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: A randomized, open-label, two-period, comparative, crossover study","volume":"28","author":"Park","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib16","series-title":"Guidance: Statistical procedure for bioequivalence studies using standard 2-treatment cross-over design: Statement under 21 CFR 10.9","author":"US Food and Drug Administration","year":"1992"},{"key":"10.1016\/j.clinthera.2008.05.013_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","article-title":"Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV","volume":"18","author":"Williams","year":"2004","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.clinthera.2008.05.013_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/107424849700200201","article-title":"Efficacy and safety of nifedipine coat-core versus amlodipine in patients with mild to moderate essential hypertension: Comparison of 24-hour mean ambulatory diastolic blood pressure","volume":"2","author":"Byyny","year":"1997","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2008.05.013_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1081\/CEH-100100059","article-title":"Efficacy and safety of a fixed lowdose perindopril\/indapamide combination in essential hypertension. A randomised controlled study","volume":"22","author":"Mallion","year":"2000","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.clinthera.2008.05.013_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/chir.530060704","article-title":"Enantioselective disposition of oral amlodipine in healthy volunteers","volume":"6","author":"Laufen","year":"1994","journal-title":"Chirality"},{"key":"10.1016\/j.clinthera.2008.05.013_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-4347(97)00394-0","article-title":"Pharmacokinetic behaviour of R-(+)-and S-(-)-amlodipine after single enantiomer administration","volume":"703","author":"Luksa","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.05.013_bib22","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00005344-198710001-00023","article-title":"Microvascular mechanisms involved in calcium antagonist edema formation","volume":"10","author":"Gustafsson","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2008.05.013_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0167-5273(91)90007-C","article-title":"Impaired venoarteriolar reflex as a possible cause for nifedipineinduced ankle oedema","volume":"30","author":"Salmasi","year":"1991","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2008.05.013_bib24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0895-7061(01)02178-1","article-title":"Vasodilatory edema: A common side effect of antihypertensive therapy","volume":"14","author":"Messerli","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2008.05.013_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1345\/aph.1H299","article-title":"Lercanidipine in the treatment of hypertension","volume":"41","author":"Beckey","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2008.05.013_bib26","first-page":"197202","article-title":"Multicentric, clinical trial of S-amlodipine 2.5 mg versus amlodipine 5 mg in the treatment of mild to moderate hypertension-a randomized, double-blind clinical trial","volume":"52","author":"Pathak","year":"2004","journal-title":"J Assoc Physicians India"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T21:53:59Z","timestamp":1545947639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0149291808001835"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}